ArticleCureus2023

Voxelotor Treatment Providing Transfusion Independence for Patient With Combined Sickle Cell Disease and Lipopolysaccharide-Responsive and Beige-Like Anchor (LRBA) Deficiency.

Kelsey M Larkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.